Indian Kids' genes may predict leukemia drug side effects

NCT ID NCT05512169

Recruiting now Knowledge-focused Sponsor: University of Geneva, Switzerland Source: ClinicalTrials.gov ↗

First seen Jan 18, 2026 · Last updated May 23, 2026 · Updated 16 times

Summary

This study follows 500 Indian children with acute lymphoblastic leukemia (ALL) to see how their genes influence side effects from chemotherapy and how well they respond to steroids. Researchers will collect blood samples and track health outcomes over five years. The goal is to find genetic markers that could help personalize treatment and reduce harmful side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PEDIATRIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Dr. Biswajit Dubashi
RECRUITING

Puducherry, 605006, India

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Dr. Sameer Bakhshi
RECRUITING

New Delhi, 110029, India

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

ADVERSE DRUG EVENT ALL, CHILDHOOD DRUG EFFECT DRUG INTERACTION DRUG TOXICITY PEDIATRIC CANCER RELAPSE LEUKEMIA RELAPSE LEUKEMIA TOXICITY, DRUG